Walton Centre for Neurology and Neurosurgery
Welcome,         Profile    Billing    Logout  
 3 Trials 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Young, Carolyn
COURAGE-ALS, NCT04944784 / 2020-004040-29: A Study to Evaluate the Efficacy and Safety of Reldesemtiv in Patients With Amyotrophic Lateral Sclerosis (ALS)

Terminated
3
489
Europe, Canada, US, RoW
Reldesemtiv, Placebo
Cytokinetics
Amyotrophic Lateral Sclerosis
07/23
07/23
ChariotMS, NCT04695080 / 2018-005038-39: - Cladribine to Halt Deterioration in People With Advanced Multiple Sclerosis

Recruiting
2/3
200
Europe
Cladribine (MAVENCLAD®), Placebo
Queen Mary University of London, National Institute for Health Research, United Kingdom, Merck Serono Limited, UK, Multiple Sclerosis Society of Great Britain & Northern Ireland, National Multiple Sclerosis Society, Barts & The London NHS Trust
Advanced Multiple Sclerosis, Progressive Multiple Sclerosis
12/24
12/27
Marson, ssor Anthony
BIOJUME, NCT03400371: Biology of Juvenile Myoclonic Epilepsy

Recruiting
N/A
1000
Europe, Canada, US, RoW
Blood draw, Existing samples
King's College London, King's College Hospital NHS Trust, Charles University, Czech Republic, Hopital Universitaire Robert-Debre, Vestre Viken Hospital Trust, The Hospital for Sick Children, Cardiff University, Odense University Hospital
Juvenile Myoclonic Epilepsy
06/25
06/26

Download Options